📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host. (2018)

First Author: Calvo-Pinilla E

Attributed to: Expression and formulation of Bluetongue virus genes and proteins for development of effective vaccination strategies funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.antiviral.2018.04.015

PubMed Identifier: 29678552

Publication URI: http://europepmc.org/abstract/MED/29678552

Type: Journal Article/Review

Volume: 154

Parent Publication: Antiviral research

ISSN: 0166-3542